Abstract
Purpose
Findings from randomized clinical trials have shown that survival in patients with sentinel lymph node (SLN)-negative breast cancer is noninferior with SLN biopsy (SLNB) alone versus further axillary lymph node dissection (ALND). However, the long-term outcome of these two surgical approaches in pN0 breast cancer patients in real-world setting remains uncertain.
Methods
We included patients diagnosed with pathologically staged T1-2N0M0 breast cancer between 2000 and 2015 in surveillance, epidemiology, and end results 18-registry database. Patients were considered to have undergone SLNB alone if they had ≤ 5 examined lymph nodes (ELNs), and ALND if they had ≥ 10 ELNs. The outcomes included overall survival (OS) and breast cancer-specific survival. Propensity score analyses by weighting and matching and multivariable Cox regression analysis were performed to minimize treatment selection bias.
Results
We included 309,430 patients (253,501 SLNB and 55,929 ALND). In the weighted cohort, ALND was associated with significantly lower OS (hazard ratio [HR] 1.13; 95% confidence interval [CI] 1.10–1.16) and BCSS (HR 1.16; 95% CI 1.10–1.22) compared with SLNB alone. Both the propensity score-matching model and multivariable Cox model demonstrated a survival benefit for SLNB when compared with ALND. Subgroup analyses for key variables did not change these findings.
Conclusion
We found statistically significant differences in OS and BCSS between SLNB and ALND, though the magnitude of these differences was small. Our findings further support that SLNB alone should be the standard of care for patients who do not have metastatic lymph nodes identified during breast cancer surgery.
Similar content being viewed by others
References
Lyman GH, Somerfield MR, Bosserman LD et al (2017) Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 35:561–564. https://doi.org/10.1200/JCO.2016.71.0947
Veronesi U, Paganelli G, Viale G et al (2003) A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 349:546–553. https://doi.org/10.1056/NEJMoa012782
Veronesi U, Paganelli G, Viale G et al (2006) Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol 7:983–990. https://doi.org/10.1016/S1470-2045(06)70947-0
Veronesi U, Viale G, Paganelli G et al (2010) Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized controlled study. Ann Surg 251:595–600. https://doi.org/10.1097/SLA.0b013e3181c0e92a
Purushotham AD, Upponi S, Klevesath MB et al (2005) Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23:4312–4321. https://doi.org/10.1200/JCO.2005.03.228
Mansel RE, Fallowfield L, Kissin M et al (2006) Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial. J Natl Cancer Inst 98:599–609. https://doi.org/10.1093/jnci/djj158
Zavagno G, De Salvo GL, Scalco G et al (2008) A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 247:207–213. https://doi.org/10.1097/SLA.0b013e31812e6a73
Canavese G, Catturich A, Vecchio C et al (2009) Sentinel node biopsy compared with complete axillary dissection for staging early breast cancer with clinically negative lymph nodes: results of randomized trial. Ann Oncol 20:1001–1007. https://doi.org/10.1093/annonc/mdn746
Krag DN, Anderson SJ, Julian TB et al (2010) Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial. Lancet Oncol 11:927–933. https://doi.org/10.1016/S1470-2045(10)70207-2
Agresti R, Martelli G, Sandri M et al (2014) Axillary lymph node dissection versus no dissection in patients with T1N0 breast cancer: a randomized clinical trial (INT09/98). Cancer 120:885–893. https://doi.org/10.1002/cncr.28499
Canavese G, Bruzzi P, Catturich A et al (2016) Sentinel lymph node biopsy versus axillary dissection in node-negative early-stage breast cancer: 15-year follow-up update of a randomized clinical trial. Ann Surg Oncol 23:2494–2500. https://doi.org/10.1245/s10434-016-5177-4
Gradishar WJ, Anderson BO, Abraham J et al (2020) Breast cancer, version 3.2020, NCCN clinical practice guidelines in oncology. j natl compr canc netw 18:452–478. https://doi.org/10.6004/jnccn.2020.0016
Cox C, White L, Allred N et al (2006) Survival outcomes in node-negative breast cancer patients evaluated with complete axillary node dissection versus sentinel lymph node biopsy. Ann Surg Oncol 13:708–711. https://doi.org/10.1245/ASO.2006.05.017
Kuijt GP, van de Poll-Franse LV, Voogd AC et al (2007) Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Eur J Surg Oncol 33:832–837. https://doi.org/10.1016/j.ejso.2006.11.017
Langer I, Guller U, Hsu-Schmitz SF et al (2009) Sentinel lymph node biopsy is associated with improved survival compared to level I & II axillary lymph node dissection in node negative breast cancer patients. Eur J Surg Oncol 35:805–813. https://doi.org/10.1016/j.ejso.2008.09.006
Moon H-G, Han W, Noh D-Y (2010) Comparable Survival Between pN0 Breast Cancer Patients Undergoing Sentinel Node Biopsy and Extensive Axillary Dissection: A Report From the Korean Breast Cancer Society. J Clin Oncol 28:1692–1699. https://doi.org/10.1200/JCO.2009.25.9226
Lunceford JK, Davidian M (2004) Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study. Stat Med 23:2937–2960. https://doi.org/10.1002/sim.1903
Austin PC, Stuart EA (2015) Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med 34:3661–3679. https://doi.org/10.1002/sim.6607
Austin PC (2014) The use of propensity score methods with survival or time-to-event outcomes: reporting measures of effect similar to those used in randomized experiments. Stat Med 33:1242–1258. https://doi.org/10.1002/sim.5984
Austin PC (2011) Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 10:150–161. https://doi.org/10.1002/pst.433
Ding P, VanderWeele TJ (2016) Sensitivity analysis without assumptions. Epidemiology 27:368–377. https://doi.org/10.1097/EDE.0000000000000457
Garcia-Etienne CA, Mansel RE, Tomatis M et al (2019) Trends in axillary lymph node dissection for early-stage breast cancer in Europe: Impact of evidence on practice. The Breast 45:89–96. https://doi.org/10.1016/j.breast.2019.03.002
Riedel F, Heil J, Golatta M et al (2019) Changes of breast and axillary surgery patterns in patients with primary breast cancer during the past decade. Arch Gynecol Obstet 299:1043–1053. https://doi.org/10.1007/s00404-018-4982-3
Yen TWF, Laud PW, Sparapani RA, Nattinger AB (2014) Surgeon specialization and use of sentinel lymph node biopsy for breast cancer. JAMA Surg 149:185–192. https://doi.org/10.1001/jamasurg.2013.4350
Yen TWF, Laud PW, Pezzin LE et al (2018) Prevalence and Consequences of Axillary Lymph Node Dissection in the Era of Sentinel Lymph Node Biopsy for Breast Cancer. Med Care 56:78–84. https://doi.org/10.1097/MLR.0000000000000832
Nayyar A, Strassle PD, Schlottmann F et al (2020) Disparities in the Use of Sentinel Lymph Node Dissection for Early Stage Breast Cancer. J Surg Res 254:31–40. https://doi.org/10.1016/j.jss.2020.03.063
Weir L, Speers C, D’yachkova Y, Olivotto IA (2002) Prognostic significance of the number of axillary lymph nodes removed in patients with node-negative breast cancer. J Clin Oncol 20:1793–1799. https://doi.org/10.1200/JCO.2002.07.112
Polednak AP (2003) Survival of lymph node-negative breast cancer patients in relation to number of lymph nodes examined. Ann Surg 237:163–167. https://doi.org/10.1097/01.SLA.0000048552.84451.C5
Mamounas EP, Kuehn T, Rutgers EJT, von Minckwitz G (2017) Current approach of the axilla in patients with early-stage breast cancer. Lancet. https://doi.org/10.1016/S0140-6736(17)31451-4
Meiers P, Cil T, Guller U, Zuber M (2013) Sentinel lymph node biopsy in early-stage breast cancer patients: improved survival through better staging? Langenbecks Arch Surg 398:687–690. https://doi.org/10.1007/s00423-012-1037-2
de Boer M, van Deurzen CHM, van Dijck JAAM et al (2009) Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med 361:653–663. https://doi.org/10.1056/NEJMoa0904832
Weaver DL, Ashikaga T, Krag DN et al (2011) Effect of occult metastases on survival in node-negative breast cancer. N Engl J Med 364:412–421. https://doi.org/10.1056/NEJMoa1008108
Galimberti V, Cole BF, Zurrida S et al (2013) Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial. Lancet Oncol 14:297–305. https://doi.org/10.1016/S1470-2045(13)70035-4
Giuliano AE, Hunt KK, Ballman KV et al (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305:569–575. https://doi.org/10.1001/jama.2011.90
Pantel K, Brakenhoff RH (2004) Dissecting the metastatic cascade. Nat Rev Cancer 4:448–456. https://doi.org/10.1038/nrc1370
Pereira ER, Kedrin D, Seano G et al (2018) Lymph node metastases can invade local blood vessels, exit the node, and colonize distant organs in mice. Science 359:1403–1407. https://doi.org/10.1126/science.aal3622
Lee C, Jeong S, Jang C et al (2019) Tumor metastasis to lymph nodes requires YAP-dependent metabolic adaptation. Science 363:644–649. https://doi.org/10.1126/science.aav0173
Tacconi C, Commerford CD, Dieterich LC et al (2021) CD169+ lymph node macrophages have protective functions in mouse breast cancer metastasis. Cell Rep 35:108993. https://doi.org/10.1016/j.celrep.2021.108993
Bilimoria KY, Bentrem DJ, Hansen NM et al (2009) Comparison of sentinel lymph node biopsy alone and completion axillary lymph node dissection for node-positive breast cancer. J Clin Oncol 27:2946–2953. https://doi.org/10.1200/JCO.2008.19.5750
Wang J, Mittendorf EA, Sahin AA et al (2014) Outcomes of sentinel lymph node dissection alone vs. axillary lymph node dissection in early stage invasive lobular carcinoma: a retrospective study of the surveillance, epidemiology and end results (SEER) database. PLoS ONE 9:e89778. https://doi.org/10.1371/journal.pone.0089778
Funding
This work was supported by a grant from Project funded by China Postdoctoral Science Foundation (2021M693654), National Natural Science Foundation of China (U1601224), and Natural Science Foundation of Guangdong Province (2019A1515011945).
Author information
Authors and Affiliations
Contributions
Conception and design: QZ and SW. Financial support: QZ and SW. Administrative support: SW. Provision of study materials or patients: QZ, HL, and WX. Collection and assembly of data: QZ, HL, WX, and SW. Data analysis and interpretation: QZ, HL, WX, and SW. Manuscript writing: All authors. Final approval of manuscript: All authors. Accountable for all aspects of the work: All authors.
Corresponding author
Ethics declarations
Competing interests
The authors have no relevant financial or nonfinancial interests to disclose.
Ethical approval
The study subjects were de-identified and there was no patient contact; thus, the study is exempt from an Institutional Review Board’s review.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Zheng, Q., Luo, H., **a, W. et al. Long-term survival after sentinel lymph node biopsy or axillary lymph node dissection in pN0 breast cancer patients: a population-based study. Breast Cancer Res Treat 196, 613–622 (2022). https://doi.org/10.1007/s10549-022-06746-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-022-06746-6